Comparison of Buprenorphine to Morphine in Treatment of Neonatal Abstinence Syndrome (NAS)
Status:
Completed
Trial end date:
2017-10-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether buprenorphine is a beneficial, safe, cost
effective treatment alternative to morphine sulfate in the treatment of Neonatal Abstinence
Syndrome (NAS).
Phase:
Phase 2
Details
Lead Sponsor:
Mednax Center for Research, Education and Quality Mednax Center for Research, Education, Quality and Safety